<div id="readability-page-1"><div>[MEDIA ALERT]Flagship's early-stage companies to receive AWS cloud credits, technical support, and AI capabilities to accelerate drug discovery and scientific platforms</div><div><div> <div>CAMBRIDGE, Mass.—Flagship Pioneering, a scientific innovation engine for transformative platforms and products, and Amazon Web Services (AWS) today announced a strategic collaboration to accelerate the development and scaling of breakthrough life sciences companies.Within this collaboration, AWS will be the preferred cloud provider for Flagship, supporting its companies as they build and scale digitally native and AI-native platforms and products across human health, sustainability, and other critical scientific domains. Flagship's early-stage companies will receive comprehensive technical support to fully leverage AWS's cloud and AI services, AWS cloud credits, and go-to-market resources to reach AWS's network of customers. Flagship’s internal teams of scientists and engineers, including members of its Pioneering Intelligence Initiative, will also receive specialized support to enhance their company creation and scaling capabilities. &#34;AI is no longer a theoretical tool in the life sciences—it’s a catalyst that’s fundamentally accelerating how we understand nature and generate breakthroughs,” said Avak Kahvejian, President of Flagship Labs and General Partner, Flagship Pioneering. &#34;This collaboration with AWS will enable Flagship Labs and our companies to access more technological capabilities to push scientific boundaries further and faster.&#34;“Life science innovation increasingly depends on the ability to compute at scale, experiment rapidly, and move seamlessly from discovery to deployment,” said Jason Bennett, Vice President and Global Head of Startups at AWS. &#34;Through this collaboration with Flagship Pioneering, we're providing reliable, secure, and scalable infrastructure and AI capabilities that enable startups rapid experimentation and scaling of breakthrough discoveries, ultimately helping to transform how we approach everything from drug discovery to climate change.&#34;The collaboration follows successful collaborations between AWS and Flagship-founded companies, including Moderna and Lila Sciences.About Flagship Pioneering Flagship Pioneering invents and builds platform companies, each with the potential for multiple products that transform human health, sustainability and beyond. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, operating with $14 billion of assets under its direction as of its latest capital raise, announced in July 2024. The current Flagship ecosystem comprises more than 40 companies, including Foghorn Therapeutics, Generate Biomedicines, Inari, Indigo Agriculture, Lila Sciences, Moderna, Sana Biotechnology, Tessera Therapeutics and Valo Health.</div> </div></div></div>

SBIO

CLOU

Flagship Pioneering and Amazon Web Services (AWS) have announced a strategic collaboration aimed at accelerating drug discovery and life sciences innovation. AWS will serve as the preferred cloud provider for Flagship's early-stage companies, offering cloud credits, technical support, and AI capabilities. This partnership is designed to enhance the development of digitally native and AI-native platforms across various scientific domains. Flagship's internal teams will also receive specialized support to improve their capabilities in company creation and scaling. The collaboration builds on previous successful partnerships between AWS and Flagship-founded companies like Moderna.

- Flagship Pioneering and Amazon Web Services (AWS) have announced a partnership to enhance the development of life sciences companies by providing cloud credits, technical support, and AI capabilities.  
- This collaboration aims to help Flagship's early-stage companies build and scale innovative platforms across health and sustainability sectors, enhancing their research and deployment processes.  
- The partnership leverages past successes, such as the collaborations with Moderna and Lila Sciences, reflecting AWS's commitment to supporting scalable innovations in life sciences.

Press Releases

ALPS Medical Breakthrough

iShares Biotechnology ETF

Global X Cloud Computing ETF

Health Care Select Sector SPDR

VG Health

Marinus Pharma

SPDR S&P Biotech

VanEck Biotech ETF

iShares US Pharma

Moderna

Amazon

Direxion S&P Biotech Bull 3X

Flagship Pioneering and AWS Announce Collaboration to Accelerate Drug Discovery and Life Sciences Innovation